Cincera Therapeutics Pty Ltd

Cincera Therapeutics Pty Ltd develops therapies targeting inflammatory, fibrotic, and metabolic diseases within the biotechnology sector. The Company focuses on anti-inflammatory and anti-fibrotic drug discovery, including treatments for obesity-related conditions such as NASH. Cincera Therapeutics Pty Ltd serves patients across Australia.